MedPath

Study on the utility of the short wavelength cut filter attached to the UVA 1(340~400nm) phototherapy device for Cutaneous T-cell Lymphomas.

Not Applicable
Recruiting
Conditions
Cutaneous T-Cell Lymphomas
Registration Number
JPRN-UMIN000038988
Lead Sponsor
agoya City University Graduate School of Medical Sciences Department of Geriatric and Environmental Dermatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1 Patient who is not candidates for phototherapy. - Patient who will activate or recur malignant skin tumors. - Patient who has high carcinogenic risk(xeroderma pigmentosum, radiation therapy, internal use or touching career of arsenic etc.) - Patient who has remarkable photodermatosis(hereditary photodermatosis, albinism, porphyria, photosensitive collagen disease etc.) 2 Patient who participated other clinical studies or trials within 3 months of this study entry. 3 Pregnant or possibly pregnant women, or breastfeeding women. Women who wish to become pregnant during study participation. 4 Patient who is judged inappropriate to participate in the study by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath